Structure of Recombinant Mouse ANGPT2/Ang2 Protein
Recombinant Mouse ANGPT2/Ang2 Protein is a type of recombinant protein that is derived from the Angiopoietin-2 (Ang2) gene found in mice. It is a 60 kDa glycoprotein that is composed of 496 amino acids. The protein has a signal peptide at the N-terminus, a coiled-coil domain, and a C-terminal fibrinogen-like domain. The recombinant protein is produced by inserting the Ang2 gene into a suitable expression vector and then expressing it in a host organism such as E. coli or mammalian cells.
Activity of Recombinant Mouse ANGPT2/Ang2 Protein
Recombinant Mouse ANGPT2/Ang2 Protein plays a crucial role in regulating angiogenesis, the process by which new blood vessels are formed from pre-existing ones. It acts as a ligand for the Tie2 receptor, which is expressed on the surface of endothelial cells, smooth muscle cells, and hematopoietic stem cells. The binding of Ang2 to Tie2 leads to the activation of downstream signaling pathways that promote angiogenesis.
In addition to its pro-angiogenic activity, Recombinant Mouse ANGPT2/Ang2 Protein also has anti-apoptotic and anti-inflammatory effects on endothelial cells. It can protect endothelial cells from apoptosis induced by various stimuli, such as oxidative stress and TNF-α. Moreover, it can inhibit the production of pro-inflammatory cytokines and adhesion molecules, thereby reducing inflammation in the vasculature.
Application of Recombinant Mouse ANGPT2/Ang2 Protein
Recombinant Mouse ANGPT2/Ang2 Protein has a wide range of applications in both research and clinical settings. Its pro-angiogenic activity makes it a valuable tool for studying the mechanisms of angiogenesis and for developing new therapies for diseases that involve abnormal blood vessel formation, such as cancer and cardiovascular diseases.
One of the most important applications of Recombinant Mouse ANGPT2/Ang2 Protein is in the field of cancer research. It has been shown to promote tumor growth and metastasis by stimulating the formation of new blood vessels. Therefore, targeting Ang2 with specific inhibitors or antibodies has emerged as a potential strategy for inhibiting tumor growth and metastasis.
In addition to cancer, Recombinant Mouse ANGPT2/Ang2 Protein has also been implicated in various other diseases. For instance, it has been shown to play a role in the development of diabetic retinopathy, a common complication of diabetes that involves abnormal blood vessel growth in the retina. In this context, targeting Ang2 with specific inhibitors may have therapeutic potential for treating diabetic retinopathy.
Furthermore, Recombinant Mouse ANGPT2/Ang2 Protein has been studied as a potential therapeutic for cardiovascular diseases, such as atherosclerosis and ischemic heart disease. Its ability to promote angiogenesis and inhibit inflammation makes it a promising candidate for promoting the repair of damaged blood vessels and improving blood flow in these conditions.
In conclusion, Recombinant Mouse ANGPT2/Ang2 Protein is a versatile and important tool in the field of angiogenesis research. Its structure, activity, and various applications make it a valuable protein for understanding the mechanisms of angiogenesis and developing new treatments for diseases involving abnormal blood vessel formation. Continued research on this protein will help to further elucidate its role in various diseases and may lead to the development of novel therapies.
There are no reviews yet.